Administration of ferric derisomaltose for iron deficiency and heart failure during hospital admission or at the clinic – insights from the <scp>IRONMAN</scp> trial-Reference-Cited by-同舟云学术

Administration of ferric derisomaltose for iron deficiency and heart failure during hospital admission or at the clinic – insights from the IRONMAN trial

Published:2024-07-30 Issue: Volume: Page:
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Lee Matthew M.Y.¹^ORCID,Petrie Mark C.¹,Cleland John G.F.¹,Donnelly Patrick²,Francis Mark³,Hannah Andrew⁴,Japp Alan G.⁵,Labinjoh Catherine⁶,Lang Ninian N.¹,Manisty Charlotte⁷,Petrie Colin J.¹,Piper Susan E.⁸,Williams Simon G.⁹,Ford Ian¹⁰,Kalra Paul R.¹¹¹²¹³,

Affiliation:

1. School of Cardiovascular and Metabolic Health University of Glasgow Glasgow UK

2. South Eastern Health and Social Care Trust Belfast UK

3. Victoria Hospital Kirkcaldy UK

4. University of Aberdeen, Aberdeen Cardiovascular and Diabetes Centre Aberdeen UK

5. Edinburgh Heart Centre, Royal Infirmary of Edinburgh Edinburgh UK

6. Forth Valley Royal Hospital Larbert UK

7. University College London London UK

8. King's College Hospital NHS Foundation Trust London UK

9. University of Manchester Manchester UK

10. Robertson Centre for Biostatistics University of Glasgow Glasgow UK

11. Department of Cardiology Portsmouth Hospitals University NHS Trust Portsmouth UK

12. College of Medical, Veterinary and Life Sciences University of Glasgow Glasgow UK

13. Faculty of Science and Health University of Portsmouth Portsmouth UK

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.3394

Reference8 articles.

1. Ferric Carboxymaltose in Heart Failure with Iron Deficiency

2. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis